PL1799195T3 - Granulki zawierające paracetamol, nlpz i alkohol cukrowy wytwarzane przez wytłaczanie ze stopionego materiału - Google Patents

Granulki zawierające paracetamol, nlpz i alkohol cukrowy wytwarzane przez wytłaczanie ze stopionego materiału

Info

Publication number
PL1799195T3
PL1799195T3 PL05769055.4T PL05769055T PL1799195T3 PL 1799195 T3 PL1799195 T3 PL 1799195T3 PL 05769055 T PL05769055 T PL 05769055T PL 1799195 T3 PL1799195 T3 PL 1799195T3
Authority
PL
Poland
Prior art keywords
paracetamol
nsaid
granules
sugar alcohol
melt extrusion
Prior art date
Application number
PL05769055.4T
Other languages
English (en)
Inventor
Robert Sherry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0417942A external-priority patent/GB0417942D0/en
Priority claimed from GB0417939A external-priority patent/GB0417939D0/en
Application filed filed Critical
Publication of PL1799195T3 publication Critical patent/PL1799195T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL05769055.4T 2004-08-12 2005-08-08 Granulki zawierające paracetamol, nlpz i alkohol cukrowy wytwarzane przez wytłaczanie ze stopionego materiału PL1799195T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0417942A GB0417942D0 (en) 2004-08-12 2004-08-12 Therapeutic agents
GB0417939A GB0417939D0 (en) 2004-08-12 2004-08-12 Therapeutic agents

Publications (1)

Publication Number Publication Date
PL1799195T3 true PL1799195T3 (pl) 2016-09-30

Family

ID=35044771

Family Applications (2)

Application Number Title Priority Date Filing Date
PL05769055.4T PL1799195T3 (pl) 2004-08-12 2005-08-08 Granulki zawierające paracetamol, nlpz i alkohol cukrowy wytwarzane przez wytłaczanie ze stopionego materiału
PL05769116T PL1804772T3 (pl) 2004-08-12 2005-08-08 Granulki zawierające niesteroidowy lek przeciwzapalny i alkohol cukrowy wytwarzane przez wytłaczanie ze stopu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL05769116T PL1804772T3 (pl) 2004-08-12 2005-08-08 Granulki zawierające niesteroidowy lek przeciwzapalny i alkohol cukrowy wytwarzane przez wytłaczanie ze stopu

Country Status (14)

Country Link
US (2) US20070254028A1 (pl)
EP (2) EP1804772B1 (pl)
JP (2) JP2008509206A (pl)
KR (3) KR101232114B1 (pl)
CN (2) CN102631325A (pl)
AR (2) AR050783A1 (pl)
AT (1) ATE526949T1 (pl)
AU (3) AU2005271036B2 (pl)
CA (2) CA2576642A1 (pl)
MX (2) MX2007001597A (pl)
PL (2) PL1799195T3 (pl)
PT (1) PT1804772E (pl)
RU (2) RU2389478C2 (pl)
WO (2) WO2006016126A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
EP1808163A1 (en) * 2005-12-22 2007-07-18 Teva Pharmaceutical Industries Ltd. Compressed solid dosage forms with drugs of low solubility and process for making the same
CA2626234A1 (en) * 2005-12-22 2007-06-28 Teva Pharmaceutical Industries Ltd. Compressed solid dosage forms with drugs of low solubility and process for making the same
US8083603B2 (en) * 2007-11-09 2011-12-27 Qubicaamf Worldwide Llc Bowling bumper system and method of use and installation
JPWO2009128543A1 (ja) * 2008-04-17 2011-08-04 ニプロ株式会社 シリカを含む錠剤の製造方法、錠剤及び錠剤用複合粒子
US8759279B2 (en) * 2008-06-30 2014-06-24 Kimberly-Clark Worldwide, Inc. Fragranced biodegradable film
US20110144207A1 (en) * 2008-08-14 2011-06-16 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
PT2238974E (pt) * 2009-04-09 2013-07-09 E Pharma Trento Spa Granulado para a formulação de comprimidos orodispersíveis
RU2715680C2 (ru) * 2009-06-22 2020-03-03 ВАЙЕТ ЭлЭлСи Таблетки ибупрофена натрия и способы изготовления фармацевтических композиций, включающих ибупрофен натрия
EA019805B1 (ru) * 2010-09-16 2014-06-30 Закрытое Акционерное Общество "Афофарм" Комбинированный анальгетик на основе парацетамола
JP5750856B2 (ja) * 2010-10-04 2015-07-22 ライオン株式会社 固形医薬組成物及び医薬製剤
RU2449777C1 (ru) * 2010-12-20 2012-05-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет, НГУ) Способ получения высокодисперсного парацетамола
JP6255908B2 (ja) * 2012-11-09 2018-01-10 大正製薬株式会社 固形製剤
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
WO2014106962A1 (ko) 2013-01-07 2014-07-10 삼아제약 주식회사 향상된 용해도를 갖는 신규한 속용성 과립제형
CN104723597B (zh) * 2015-03-23 2017-04-05 辽宁天亿机械有限公司 一种间歇式压片机
WO2018197932A1 (en) * 2017-04-27 2018-11-01 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions of ketorolac
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol
CN114041519A (zh) * 2021-11-25 2022-02-15 浙江华康药业股份有限公司 一种制备可直接压片木糖醇颗粒的方法
AU2022201576A1 (en) * 2022-03-08 2023-09-28 Aft Pharmaceuticals Limited Medication
CN120152707A (zh) * 2022-11-04 2025-06-13 科赴品牌有限责任公司 用于治疗疼痛的对乙酰氨基酚和萘普生

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH677606A5 (pl) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
US5075291A (en) * 1989-11-22 1991-12-24 Ici Americas Inc. Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound
SK279279B6 (sk) * 1991-05-13 1998-09-09 The Boots Company Plc S(-)-nátrium-2-(4-izobutylfenyl)propionát-dihydrát
DE122004000032I2 (de) * 1991-09-06 2006-02-09 Mcneilab Inc Zusammensetzung die eine Tramadol-Verbindung und Acetaminophen enth{lt, und ihre Verwendung
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
FR2705677B1 (fr) * 1993-05-28 1995-08-11 Roquette Freres Micro-granules obtenus par extrusion-sphéronisation contenant une cyclodextrine.
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
DE19710213A1 (de) * 1997-03-12 1998-09-17 Basf Ag Verfahren zur Herstellung von festen Kombinationsarzneiformen
DE19809242A1 (de) * 1998-03-05 1999-09-09 Basf Ag Verfahren zur Herstellung von festen, sphärischen Formkörpern, enthaltend pharmazeutische Wirkstoffe in einer Bindemittelmatrix
EP1301186A1 (en) * 2000-07-19 2003-04-16 Lavipharm Laboratories, Inc. Sildenafil citrate solid dispersions having high water solubility
FR2814366A1 (fr) * 2000-09-22 2002-03-29 Rhodia Chimie Sa Procede de granulation de matieres actives par extrusion basse pression pour l'obtention de granules directement compressibles
US20030008003A1 (en) * 2001-04-10 2003-01-09 Fahkreddin Jamali Compositions for enhanced absorption of NSAIDs
US6872405B2 (en) * 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
GB0113842D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113843D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US6766817B2 (en) * 2001-07-25 2004-07-27 Tubarc Technologies, Llc Fluid conduction utilizing a reversible unsaturated siphon with tubarc porosity action
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.

Also Published As

Publication number Publication date
CN102631325A (zh) 2012-08-15
CA2576652A1 (en) 2006-02-16
KR20130014647A (ko) 2013-02-07
RU2007108778A (ru) 2008-09-20
RU2389478C2 (ru) 2010-05-20
ATE526949T1 (de) 2011-10-15
WO2006016126A1 (en) 2006-02-16
PT1804772E (pt) 2011-12-02
KR20070069143A (ko) 2007-07-02
JP2008509207A (ja) 2008-03-27
RU2007108779A (ru) 2008-09-20
KR101482922B1 (ko) 2015-01-15
EP1804772A1 (en) 2007-07-11
AU2005271035B2 (en) 2009-09-17
PL1804772T3 (pl) 2012-03-30
KR20070062978A (ko) 2007-06-18
US20080085308A1 (en) 2008-04-10
KR101232114B1 (ko) 2013-02-13
CA2576642A1 (en) 2006-02-16
EP1804772B1 (en) 2011-10-05
EP1799195A1 (en) 2007-06-27
AU2010200633B2 (en) 2013-01-31
EP1799195B1 (en) 2016-03-23
MX2007001689A (es) 2007-06-11
AU2005271036A1 (en) 2006-02-16
AU2005271035A1 (en) 2006-02-16
HK1104965A1 (en) 2008-02-01
AU2010200633A1 (en) 2010-03-11
AR052523A1 (es) 2007-03-21
CN102784113A (zh) 2012-11-21
WO2006016125A1 (en) 2006-02-16
JP2008509206A (ja) 2008-03-27
AU2005271036B2 (en) 2009-11-19
AR050783A1 (es) 2006-11-22
US20070254028A1 (en) 2007-11-01
RU2389480C2 (ru) 2010-05-20
MX2007001597A (es) 2007-05-23

Similar Documents

Publication Publication Date Title
PL1799195T3 (pl) Granulki zawierające paracetamol, nlpz i alkohol cukrowy wytwarzane przez wytłaczanie ze stopionego materiału
GB2456989B (en) Granules, tablets and granulation
AP2005003371A0 (en) Medication compliance device.
EP1966987A4 (en) SYSTEMS, METHODS AND MULTIMEDIA APPLICATIONS
EP1771249A4 (en) DISTRIBUTION SYSTEMS, SOFTWARE AND ASSOCIATED METHODS
EP1737545A4 (en) HORSE HELMET WITH VISOR
ZA200700498B (en) Selective insecticides based on substituted, cyclic keto-enols and safeners
EP1830205A4 (en) SEALED BONDING OPTICAL ELEMENT, OPTICAL MATERIAL USED THEREOF, RESIN RESIN AND RESIN COMPOSITION COMPOSITION
PL2851068T3 (pl) Kompozycja zawierająca NLPZ oraz paracetamol
EP1612754B8 (de) Gefahrenmelder
ZA200701029B (en) Granules comprising a NSAID and a sugar alcohol made by melt extrusion
ZA200608695B (en) Extrusion device
HK1104781A (en) Granules comprising paracetamol, a nsaid and a sugar alcohol made by melt extrusion
ATE371716T1 (de) Tabletten mit verbessertem bruchswiderstand
IL185698A0 (en) Dual wavelngth laser device, and system comprising same
GB0428226D0 (en) Dosing systems
ZA200902712B (en) Granules, tablets and granulation
GB2411616B (en) Extrudate cutting device
DK1720557T3 (da) Hurtig-opløselig, smagsmaskeret tablet
FR2859632B1 (fr) Comprime multisecable a observance amelioree.
HK1134916B (en) Granules, tablets and granulation
ES1056676Y (es) Bozal anti-estres.
AU2004901708A0 (en) Medication device
AU2004906359A0 (en) A Medication Clip
AU2004901052A0 (en) Extrudate cutting device